Press
For partnership inquiries, research collaboration, or product information, please contact us at: contact@chelseymoss.com
April, 2025
Esmé SX Is Now Raising — A New Era in Women’s Sexual Wellness Begins
“At Esmé SX, we’re not just launching a product—we’re architecting a new category.”
One where sexual wellness is seen as essential healthcare.
One where biometric intelligence and design precision converge.
One where women’s pleasure is no longer sidelined—but recognized as central to vitality and well-being.
We are officially raising our $3.25M pre-seed round at a $10M post-money SAFE to launch the world’s first biometric-responsive clitoral health platform—ushering in a new standard for intelligent intimacy and somatic innovation.
“We’re building more than a product—we’re engineering a new standard for how the body is understood, respected, and supported.”
Why Now
Women’s health is undergoing a long-overdue transformation. According to recent research, over $360B in “ghost market” opportunities exist in categories like menopause, hormonal health, and sexual wellness—massive areas of unmet need.
Esmé SX bridges this gap with a neurosomatic device that doesn’t just stimulate—it listens, responds, and evolves with the body in real time.
Additional market drivers:
Women’s Health Investment Reaches Record $2.6B in 2024, according to Silicon Valley Bank (source: SVB Report)
U.S. Spending on Wellness Hits $2 Trillion for the First Time, reflecting a profound shift in consumer values (source: Mansion Global)
“The future of health isn’t just clinical. It’s connected.”
What We’ve Built
Our debut product, Esmé SX Modal One, is the first-of-its-kind thermoacoustic clitoral stimulation device powered by adaptive biosensing—designed to create real-time resonance between a woman’s body and the technology attuning to it.
The platform integrates:
MindMics™ infrasonic biosensing (exclusive partnership) for real-time physiological signal capture
A proprietary Session Intelligence Engine that adapts stimulation to breath, rhythm, and biometric state
Multimodal sensory output — including thermal pulses, sonic waveforms, and dynamic haptic feedback
An ecosystem-ready architecture, built for seamless expansion into:
Internal stimulation modules (vaginal, G-spot, cervical)
The AI Companion App for personalized control, mood sync, and journaling
Lume™ Ritual Skincare for pre- and post-session integration
Use of Funds
This raise will fund:
Completion of MVP and pilot protocol
Final engineering validation + DFM (Nova Product Development)
Initial production of 10K units and go-to-market rollout
Team expansion, operational readiness, and 18-month runway
Strategic Partnerships
MindMics – exclusive biometric integration
Master & Dynamic – anticipated audio hardware integration via MindMics ecosystem
Skirt Club – community access to 150K high-intent women
Scientific and Product Leadership
Dr. KaT Zarychta, Chief Medical Advisor
Prof. Tony Kent, Chief Scientific Officer
Dr. Christine May, Chief Product Officer
Erin Orden, Creative Director
Steve Ardire, Strategic Advisor & Investor Relations
Connect
To request our investor packet or set up a call:
contact@chelseymoss.com
We’re not just building a product.
We’re answering a deeper call.
We are also prioritizing risk mitigation and early-stage validation through:
A pilot study protocol designed to test session effectiveness, biometric syncing, and UX engagement across a diverse user group
A modular engineering approach to de-risk technical milestones while maintaining design flexibility
Strategic advisory from medical, scientific, and manufacturing partners to ensure scalability and regulatory alignment
“We’re scaling intentionally—with scientific rigor, brand integrity, and founder-led clarity.”
Who We’re Looking For
We are seeking vision-aligned investors who believe in:
The intelligence of the female body
The power of resonance-based technology
Creating category-defining health platforms from the ground up
If that’s you—we welcome the conversation.
“This is more than a raise—it’s a reclaiming of the body’s intelligence.”
Esmé SX and MindMics Announce Strategic Partnership to Advance Biometric Intelligence in Women’s Sexual Wellness
April 2025
At the forefront of female-founded innovation, sexual wellness technology company Esmé SX and advanced digital health company MindMics have announced a strategic partnership to expand access to personalized, biometric-powered insights for women’s health and pleasure.
Esmé SX is redefining the $115B sexual wellness industry with a first-of-its-kind, biometric-responsive platform combining thermoacoustic stimulation, adaptive feedback, and real-time biometric intelligence. The company’s debut device delivers deep-wave clitoral stimulation designed to promote nerve cell activation, synaptic plasticity, and enhanced neurochemistry for expanded and multi-orgasmic experiences.
“In general, it takes women 20–30 minutes to reach climax—partly due to blood flow from the brain to the pelvic region. A dysregulated nervous system braces against receptivity. Our partnership with MindMics gives women real-time biofeedback to identify when they’re in a state of Rest & Digest —unlocking new pathways to pleasure through breath, sound, and embodied awareness.” — Chelsey Moss, CEO, Esmé SX
MindMics’ breakthrough in-ear infrasonic technology captures real-time biometric data through a new science known as infrasonic hemodynography—enabling sub-heart rate fidelity with clinical-grade precision.
“We are thrilled to partner with Esmé SX, as they bring a fresh, holistic approach to sexual wellness. We believe that our real-time biofeedback technology can offer a results-oriented method to help women discover the most effective strategies for their well-being. This collaboration aligns perfectly with our goal to empower individuals by providing personalized and actionable health insights.”
— Dr. Anna Barnacka, CEO, MindMics
Together, Esmé SX and MindMics deliver a neurosomatic approach to sexual wellness—merging precision biometric tracking with adaptive clitoral stimulation to help women optimize their orgasmic response, regulate their nervous system, and unlock deeper insights into their health.
The Esmé SX White Paper Is Now Live — The Future of Biometric - Responsive Intimacy
March 2025
Published by Esmé SX
Lead Author: Chelsey Moss, Founder & CEO
Advancing Women’s Health & Wellness Through Innovation: Driving Change with Science-Backed Solutions
Executive Summary
Esmé SX is a mission-driven technology company transforming women’s health and wellness through science-backed innovation. By combining cutting-edge research with pioneering product development, Esmé SX is closing the healthcare gap and delivering targeted solutions for women’s unique needs. Our commitment to advancing sexual wellness and overall well-being empowers women to live healthier, happier lives — redefining the future of women’s health.
The Women’s Health Gap: A Critical Need for Innovation Women’s health has historically been under-researched, underfunded, and underserved. Despite accounting for over 50% of the global population, women face significant gaps in diagnosis, treatment, and access to personalized care. Additionally, the global femtech market is projected to grow significantly, with increasing consumer demand for personalized, science-backed solutions addressing hormonal balance, sexual wellness, and mental health. Read Full Report
Dr. Zarychta’s expertise in biomedical engineering and her proven ability to assess the potential of novel technologies make her an invaluable asset to Esmé SX. Her strong technical foundation, combined with her business acumen and global leadership experience across Europe, Asia-Pacific, and the Middle East, enables her to effectively advise on navigating complex challenges and driving impactful results in the healthcare industry.
Welcoming Dr. KaT Zarychta as Chief Medical Advisor — Advancing Scientific Integrity in Women's Sexual Wellness
January 2025
Esmé SX Welcomes Dr. KaT Zarychta as Chief Medical Advisor
We at Esmé SX are elated to have Dr. KaT Zarychta join our team as Chief Medical Advisor; ensuring the scientific rigor of Esmé SX's revolutionary resonant frequency technology and guiding our mission to bridge the gap between sexual wellness and overall health — empowering women to achieve optimal well-being.
A warm welcome:
Dr. Katarzyna Zarychta, PhD, MSc Eng, is the Chief Medical Advisor at Esmé SX, leveraging over 20 years of experience in the healthcare industry. Driven by a passion for innovation and a deep understanding of holistic health, Dr. Zarychta holds a PhD in Laser Physics from Sorbonne University (Paris), Master's degrees in Physics and Biomedical Engineering, and has completed executive programs at Harvard Business School and Harvard Medical School. This robust academic foundation, coupled with her experience evaluating groundbreaking medical devices and digital health solutions for the European Commission, demonstrates her unwavering commitment to advancing innovation and well-being.